PharmaVoice

MAY 21, 2025

Utpal Singh joined the peptide-focused biotech Zealand Pharma last month after it notched a massive obesity deal with Roche.

179

179

The Guardian - Pharmaceutical Industry

MAY 21, 2025

Brand shifts away from dieting towards weight-loss injections after filing for bankruptcy in the US WeightWatchers is teaming up with a provider of weight-loss drugs such as Wegovy and Mounjaro, in a seismic shift for the brand away from a focus on dieting as it tries to turn around its struggling business. WeightWatchers, which has promoted a non-medical, points-based approach to food intake since its creation in the 1960s , has announced a strategic partnership in the UK with CheqUp, a provide

66

66

Express Pharma

MAY 21, 2025

Senores Pharmaceuticals, through its wholly-owned subsidiary Senores Pharmaceuticals, USA, has signed an agreement to acquire the USFDA-approved Abbreviated New Drug Application (ANDA) for Enalapril Maleate Tablets 2.5mg, 5mg, 10mg and 20mg from Wockhardt. Enalapril is indicated as a treatment of hypertension, heart failure, and asymptomatic left ventricular dysfunction.

66

66

pharmaphorum

MAY 21, 2025

BioNTech has said it will commit up to 1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector

105

105

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharmacy Joe

MAY 21, 2025

In this episode, Ill discussthree ways to tell the difference between serotonin syndrome and neuroleptic malignant syndrome. Episode 1028: Three ways to tell the difference between serotonin syndrome and neuroleptic malignant syndrome Subscribe on iTunes , Android , or Stitcher Muscular rigidity, significant hyperthermia, and autonomic instability are all common features of serotonin syndrome and neuroleptic malignant syndrome.

Hospitals 52

Hospitals Inpatient 52

pharmaphorum

MAY 21, 2025

UK to start "world first" gonorrhoea vaccine programme Phil.

Vaccines 66

Vaccines 66

pharmaphorum

MAY 21, 2025

Players, current and emergent, should prepare for complexities in the supply chain as radiotherapeutics continues to rise.

64

64

Drug Patent Watch

MAY 21, 2025

"The Prescription for Savings: How Smart Pharma Procurement Can Cut Costs Without Compromising Care As the pharmaceutical industry continues to evolve, one thing remains clear: the cost of prescription medications is a burden that's only getting heavier. But what if you could buy smart, not hard? A new guide from Drug Patent Watch reveals the secrets to savvy pharma procurement, helping healthcare leaders make informed decisions that put patients first.

77

77

Pharmacy Times

MAY 21, 2025

In a major policy shift, officials from the FDA announced a new regulatory framework for COVID-19 vaccinations, prioritizing adults aged 65 and older and individuals with serious comorbidities putting them at high risk for severe COVID-19.

Vaccines 52

Vaccines 52

BioPharma Dive

MAY 21, 2025

Founded in 2021, ReproNovo has licensed rights to two drugs from Mereo BioPharma and ObsEva that it thinks could address fertility issues in men and women.

59

59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

PharmaTech

MAY 21, 2025

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only multiple myeloma, but other specific cancers as well.

59

59

Pharma Marketing Network

MAY 21, 2025

Pharma email marketing platforms are no longer just digital toolstheyre the nerve center of healthcare communications in 2025. As more pharmaceutical brands race to connect with healthcare professionals (HCPs), payers, and patients in a compliant, data-driven way, the right platform makes all the difference. But how do you pick a platform that not only delivers strong ROI but also ensures HIPAA compliance, consent management, and CRM integration?

HIPAA 52

HIPAA Communication 52

Pharmaceutical Commerce

MAY 21, 2025

In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.

Vaccines 52

Vaccines 52

Pharma Marketing Network

MAY 21, 2025

Is your pharma brand generating leadsor just collecting contact forms? In a space as regulated and complex as pharmaceutical marketing, Lead Gen isnt just about volume. Its about conversion, compliance, and strategic targeting of healthcare professionals (HCPs), payers, and sometimes patients. While many life sciences companies continue to invest in email sign-ups and gated assets, far fewer have a consistent lead nurturing strategy that turns those leads into meaningful engagements or qualified

HIPAA 52

HIPAA Biosimilars 52

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharmaceutical Technology

MAY 21, 2025

The US Food and Drug Administration (FDA) is set to restrict the Covid-19 booster doses to older adults and those at risk of severe illness.

52

52

pharmaphorum

MAY 21, 2025

UK psychedelic medicines developer Beckley Psytech has said its candidate for treatment-resistant depression has enhanced the effect of standard antidepressants in a phase 2 trial.The top-line data comes from the next stage (Part 2) of its ongoing trial looking at a single dose of Beckley's BPL-003 in 12 patients given on top of standard SSRI antidepressant therapy.

51

51

Pharmaceutical Commerce

MAY 21, 2025

Ruth Beadle, head, global supply chain, Sanofi, discusses how digital integration, advanced planning, and sustainability goals are transforming end-to-end supply chain operations to improve scale, speed, and environmental impact.

52

52

PharmaTech

MAY 21, 2025

Grifols received FDA clearance to begin a Phase II trial of GRF312, an immunoglobulin eye drop for dry eye disease, aiming to improve current treatments.

52

52

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmaceutical Technology

MAY 21, 2025

Viz.ai is set to enter into a multi-year collaboration with Sanofi and Regeneron for the management of COPD.

52

52

PharmaTech

MAY 21, 2025

Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development of genetic medicines.

52

52

Pharmaceutical Technology

MAY 21, 2025

BioNTech has entered a grant agreement with the UK government to expand its research and development (R&D) activities for medicines.

52

52

Drug Channels

MAY 21, 2025

The Inflation Reduction Act (IRA) is triggering increases in Medicare beneficiaries spending on their Part B drugs. Though CMS touts that the IRAs inflation-based coinsurance adjustments will "lower out-of-pocket costs," the results have been more complicated. Below, we update and expand on our previous analysis. We find that a growing number of Part B drugs now have inflation-adjusted coinsurance rates that are rising, not falling.

Drug Pricing 52

Drug Pricing 52

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

MAY 21, 2025

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary for response.

52

52

pharmaphorum

MAY 21, 2025

Watch an insightful video interview with Mehul Desai as he challenges conventional wisdom on injectables and shares his unique perspective on the topic. Gain new insights and knowledge in this engaging conversation.

52

52

Pharmaceutical Technology

MAY 21, 2025

Despite the boost to contributions, WHO has downsized its 2026-27 budget by over $1bn due to financial constraints.

52

52

PharmExec

MAY 21, 2025

Results from the Phase II WILLOW trial show that enpatoran achieved a statistically significant dose-response and clinically meaningful reduction in disease activity in cutaneous and systemic lupus erythematosus with active rash.

40

40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

MAY 21, 2025

We learn how the EUs new Clinical Trial Regulation (CTR) and the CTIS platform are reshaping clinical trial approvals and the supply chain.

52

52

PharmExec

MAY 21, 2025

In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.

Vaccines 40

Vaccines 40

Pharmaceutical Technology

MAY 21, 2025

GSK will incorporate the findings into messaging that depemokimab patients will adhere to treatment better, ensuring better outcomes.

52

52

PharmExec

MAY 21, 2025

Positive feedback was based on Phase III AQUILA trial results, which showed a significant clinical benefit with Darzalex Faspro in patients with high-risk smoldering multiple myeloma.

40

40

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management